Alessandro Bonardi

17PUBLICATIONS
42CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Feb 23, 2026
Sideroxylonal B: A Dimeric Phloroglucinol From Eucalyptus cinerea With In Vitro Carbonic Anhydrase Inhibition and Evaluation of Cytotoxicity and Antiviral Potential.

Fatema R Saber, Alessandro Bonardi, Rasha A Hassan

|Feb 08, 2026
Benzoxaboroles Are Inhibitors of the η-Class Carbonic Anhydrase From Plasmodium falciparum.

Alessandro Bonardi, Sharon Wein, Muhamad Mustafa

|Jan 28, 2026
Investigation on <i>N</i>-Aryl-2-(4-sulfamoylphenyl)hydrazine-1-carbothioamide as Human Carbonic Anhydrases Inhibitors.

Morteza Abdoli, Andrea Angeli, Alessandro Bonardi

|Oct 16, 2025
Exploration of New Pyrazole-Hydrazone-Benzenesulfonamide Conjugates as Potent Mycobacterial Carbonic Anhydrase Inhibitors: Design, Synthesis, and Biological Evaluation.

Pardeep Kumar, Anuradha Singampalli, Rani Bandela

|Apr 01, 2025
Exploration of Aromatic Hydrazides as Inhibitors of Human Carbonic Anhydrases.

German Benito Menendez, Simone Giovannuzzi, Alessandro Bonardi

|Dec 17, 2024
New 7-hydroxycoumarin acetamide derivatives as human carbonic anhydrase IX and XII inhibitors: Design, synthesis, biological evaluation and molecular docking studies.

Sarvan Maddipatla, Bulti Bakchi, Mayura Anil Shinde

Pageof 3

Frequent Collaborators

13 joint publications

Claudiu T Supuran

11 joint publications

Paola Gratteri

6 joint publications

Raivis Žalubovskis

5 joint publications

Alessio Nocentini